Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bone Biologics Corp

BBLG ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.66

▼ -2.86%

Market Cap $1.19M · Vol 9.23K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.19M

Micro Cap

Div Yield

N/A

EPS Growth

+55.85%

YoY

RSI (14)

25.00

Momentum

Beta

0.93

vs Market

52W High

$3.99

83.58% below

52W Low

$0.62

5.65% above

Volume

9.23K

Avg 38.64K

P/B

0.48

Price-to-book

ROE

N/A

Return on equity

Free Float

99.96%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bone Biologics Corp (BBLG) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BBLG pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-29.76%

-48.02%

-48.43%

-46.31%

YTD

-54.83%

-72.13%

-98.32%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-3,108,990.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-64.38% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.48
P/FCF	N/A
EPS Growth	+55.85%
Outstanding Shares	1.81M

Technical Indicators

50-Day SMA	$1.17
200-Day SMA	$1.40
RSI (14)	25.00
Beta	0.93
52-Week High	$3.99
52-Week Low	$0.62

Volume Today	9.23K
Avg Daily Volume (30D)	38.64K
Relative Volume	0.24x
Volatility (10D)	167.37
Volatility (30D)	106.00
Free Float	99.96%

Analyst Consensus

N/A

Current Price $0.66

Mean Target $12.20

52W Low$0.62 52W High$3.99

Current

Target

$0.62 $3.99

Current Analyst target

+1,762.60% upside potential · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG007GF2K79

ISINUS0980706008

CountryUnited States of America

Sub-IndustryBio Medical Devices

Earnings DateAug 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MDXG MiMedx Group Inc +1.67% BONS.TA Bonus Biogroup Ltd -1.35% ALNOV.PA Novacyt SA +0.78% 2359.HK WuXi AppTec Co Ltd -2.85% ARGX argenx SE -0.66%

Company Profile

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.